Del Carpio OL, Aguilar SA

Language: Spanish
References: 13
Page: 365-367
PDF size: 204.67 Kb.

ABSTRACT

In this communication we discuss the epidemiological panorama of dengue, which is being changed by influences of the ecological triad, from climatic changes and geographic hot spots that favor the interrelationship between arboviruses, vectors, and hosts, adjustments of the virus itself, with more serotypes predominating virulent and pathogenic than others, as well as the presence of other vector species with vector capacity that ensure the distribution of the virus in regions not previously seen. The current status of treatments and vaccines with important advances regarding this arboviral disease is also discussed.

REFERENCES

1. Lozano-Fuentes S, Hayden MH, Welsh-Rodriguez C, Ochoa-Martinez C, et al. The dengue virus mosquito vector Aedesaegypti at high elevation in Mexico. Am J Trop Med Hyg 2012; 87 (5): 902-9. doi: 10.4269/ajtmh.2012.12-0244

2. https://www.gob.mx/cms/uploads/attachment/file/789466/Pano_dengue_52_2022.pdf

3. https://www.gob.mx/cms/uploads/attachment/file/800992/Pano_dengue_04_2023.pdf

4. Luo Q. [A study on transmission of dengue virus by Culex fatigans].Zhonghua Liu Xing Bing Xue Za Zhi 1993; 14 (2): 67-9.

5. Barrio-Nuevo KM, Cunha MS, Luchs A, Fernandes A, et al.Detection of Zika and dengue viruses in wild-caught mosquitoescollected during field surveillance in an environmentalprotection area in São Paulo, Brazil. PLoS One 2020;15 (10): e0227239. doi: 10.1371/journal.pone.0227239

6. Del Carpio-Orantes L. Culex y Aedes vexans, vectoresconfirmados de Zika en México. Med Int Mex 2019; 35(6): 931-933. https://doi.org/10.24245/mim.v35i6.2922

7. Del Carpio-Orantes L, Mejía-Ramos SG, Aguilar-Silva A.COVID-19 and dengue coinfection in Veracruz, Mexico.Travel Med Infect Dis 2022; 50: 102467. doi: 10.1016/j.tmaid.2022.102467

8. Del Carpio-Orantes L, Moreno-Aldama NP, Sánchez-DíazJS. Caracterización clínica de dengue, chikunguña y Zikadurante 2016 en Veracruz, México. Med Int Mex 2020; 36(2): 147-152. https://doi.org/10.24245/mim.v36i2.3033

9. Dzul-Manzanilla F, Correa-Morales F, Che-Mendoza A,Palacio-Vargas J, et al. Identifying urban hotspots of dengue,chikungunya, and Zika transmission in Mexico to support riskstratification efforts: a spatial analysis. Lancet Planet Health2021; 5 (5): e277-e285. doi: 10.1016/S2542-5196(21)00030-9

10. Farfan-Morales CN, Cordero-Rivera CD, Osuna-Ramos JF,Monroy-Muñoz IE, et al. The antiviral effect of metforminon zika and dengue virus infection. Sci Rep 2021; 11 (1):8743. doi: 10.1038/s41598-021-87707-9

11. Osuna-Ramos JF, Reyes-Ruiz JM, Bautista-Carbajal P,Cervantes-Salazar M, et al. Ezetimibe inhibits denguevirus infection in Huh-7 cells by blocking the cholesteroltransporter Niemann-Pick C1-like 1 receptor. Antiviral Res2018; 160: 151-164. doi: 10.1016/j.antiviral.2018.10.024

12. Farfan-Morales CN, Cordero-Rivera CD, Reyes-Ruiz JM,Hurtado-Monzón AM, et al. Anti-flavivirus properties oflipid-lowering drugs. Front Physiol 2021; 12: 749770. doi:10.3389/fphys.2021.749770

13. Torres-Flores JM, Reyes-Sandoval A, Salazar MI. Denguevaccines: An update. BioDrugs 2022; 36 (3): 325-336. doi:10.1007/s40259-022-00531-z